NASDAQ · STOCK
Novo Nordisk A/S
$47.08
52W $35.12 – $64.16
49/100
$209.19B
11.2
0.36
Is NVO Bullish or Bearish?
Mixed.
Innellis AI committee rates Novo Nordisk A/S (NVO) Watch with a composite score of 49/100
, based on 7 analysts with 57% agreement.
Last updated July 31, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +11.38 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -8.62 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Value Analyst sees a compelling case — p/e of 12.3 is inexpensive for the broad market. Risk Analyst remains cautious — current ratio of 0.80 is tight -- limited short-term liquidity cushion. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- P/E of 12.3 is inexpensive for the broad market — Value
- ROE of 66.4% shows genuine earnings power backing the valuation — Value
- Dividend yield of 3.5% pays you to wait — Value
- MACD histogram positive -- bullish momentum — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
- Beta of 1.84 means this name should amplify a favorable market regime — Macro
Bear Case
- Price-to-book of 7.4x prices in significant intangible value — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- RSI at 70 is in overbought territory — Technical
- Current ratio of 0.80 is tight -- limited short-term liquidity cushion — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of July 31, 2026
Overall Committee Score
49/100
Agreement
57%
Analysts
7
Conviction
Contested
Sector Rank
Top 96%
of 93 Healthcare peers
Value Analyst
bullish
62
/ 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ P/E of 12.3 is inexpensive for the broad market
− Price-to-book of 7.4x prices in significant intangible value
Growth Analyst
bearish
38
/ 100 · Moderate confidence
Growth story is weak, decelerating, or inconsistent
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst
neutral
48
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− RSI at 70 is in overbought territory
Risk Analyst
bearish
35
/ 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Current ratio of 0.80 is tight -- limited short-term liquidity cushion
Macro Analyst
neutral
58
/ 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
neutral
55
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Investment Thesis Evolution
Committee score moved marginally from 47.6 to 48.6.
- Committee agreement increased notably from 43% to 57%.
- New bearish signals: 2 appeared.
- New bullish signals: 3 appeared.
- Bearish pressure eased: 4 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst, Technical Analyst.
Analyst-level changes:
- Macro Analyst: stance bullish->neutral; score 65->58 (-8); +2 bullish signal(s).
- News Analyst: score 51->55 (+4).
- Portfolio Manager: +2 bearish signal(s).
- Technical Analyst: stance bearish->neutral; score 38->48 (+10); +1 bullish signal(s).
Comparing 2026-07-30 to 2026-07-31 (1 day apart).
Technical Analysis
RSI (14)
33.8
Neutral
MACD Histogram
-0.234
Bearish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Mixed
Support
$45.06
Resistance
$47.75
Bollinger %B
-0.03
Below Lower Band
Price vs Moving Averages
EMA 9
$49.64
Below
EMA 21
$49.14
Below
EMA 50
$47.40
Below
EMA 200
$49.67
Below
Fundamental Analysis
Valuation
73
Growth
56
Profitability
2
Financial Health
44
Cash Flow
36
Valuation
P/E Ratio
11.2×
P/B Ratio
6.71×
PEG Ratio
0.67
Dividend Yield
0.04%
52W High
$64.16
52W Low
$35.12
Quality & Growth
ROE
52.8%
ROA
18.9%
Gross Margin
81.8%
Operating Margin
45.3%
Revenue Growth YoY
—
Debt / Equity
0.72
AI Fundamental Assessment
P/E ratio of 11.2 (inexpensive relative to a 15-40x range); Price-to-book of 6.7x; PEG ratio of 0.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 0.5%; Return on assets of 0.2%; Net margin of 0.4%; Gross margin of 0.8%; Current ratio of 0.79 (tight short-term liquidity); Debt-to-equity of 0.72; Free cash flow margin of 0.3% (thin cash generation); Free cash flow per share is positive (6.98); Most recent quarter beat estimates by 23.1%; 2 consecutive earnings beats; EPS growth decelerating (+34.2% -> +9.8% QoQ); Analyst estimates rising over recent quarters
Get the Full NVO Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →